301520 万邦医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1885.74512.03934.98142.652
总资产报酬率 ROA (%)2.0735.43311.09128.69233.818
投入资产回报率 ROIC (%)2.1535.64011.71232.52337.696

边际利润分析
销售毛利率 (%)30.42539.57948.93850.38252.712
营业利润率 (%)14.53022.96034.81740.67941.300
息税前利润/营业总收入 (%)14.07122.77833.65442.28044.489
净利润/营业总收入 (%)15.81022.56231.62437.86138.784

收益指标分析
经营活动净收益/利润总额(%)9.92066.12392.77088.69990.272
价值变动净收益/利润总额(%)79.82431.4985.1982.8571.965
营业外收支净额/利润总额(%)-0.1412.7450.5344.5557.576

偿债能力分析
流动比率 (X)21.85818.77420.3514.3875.105
速动比率 (X)21.84318.74820.3414.3805.101
资产负债率 (%)4.9275.6395.21718.03817.893
带息债务/全部投入资本 (%)0.4010.7970.9464.1585.416
股东权益/带息债务 (%)24,593.88412,317.59710,378.5712,252.2061,699.051
股东权益/负债合计 (%)1,929.7351,673.3491,816.848454.373458.873
利息保障倍数 (X)-32.055-27.427-24.926-123.982-226.532

营运能力分析
应收账款周转天数 (天)80.20355.51445.53033.31918.819
存货周转天数 (天)2.7092.0641.1450.8681.005